Skip to content

Evaluation of FAVAS ( Focal ambient visual acuity stimulation) digital based health application

Evaluation of FAVAS ( Focal ambient visual acuity stimulation) digital based health application - FAVAS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00030216
Enrollment
232
Registered
2022-10-28
Start date
2022-10-31
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H53.0

Interventions

Group 1: Amblyopia therapy using the Caterna visual therapy, which can be carried out online in addition to occlusion therapy. The therapy games of the Caterna vision training Played on the computer

Sponsors

Caterna Vision GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
4 Years to 12 Years

Inclusion criteria

Inclusion criteria: - Study indications according to ICD-10: H53.0 - Amblyopia ex anopsia - Medical diagnosis of amblyopia with visual acuity difference of the eyes > 0.1 log MAR or visual acuity < 0.1 log MAR in the worse eye - Refractive amblyopia - Strabismic ambyopia - Refractive and strabismic ambylopia - Age 4-12 years - Prescribed occlusion therapy with stagnant visual development under occlusion before application of the intervention/control - 90-day use of the intervention/control

Exclusion criteria

Exclusion criteria: - Patients with proven learning disabilities - Patients with - Deprivation amblyopia - Other ophthalmological pre-existing conditions such as cataracts, corneal, lens and retinal anomalies - Other pre-existing conditions that can negatively affect an independent visual prognosis - Epilepsy (G40)

Design outcomes

Primary

MeasureTime frame
The primary aim of the study is to prove that in patients who have already completed an initial standard occlusion and have a stagnant visual acuity, the subsequent 90-day use of the combination therapy of occlusion and stimulation therapy (intervention) is superior to the sole further application of the standard treatment of occlusion (control) with regard to visual development according to subjective refraction with row optotypes.

Secondary

MeasureTime frame
Improvement in stereo vision

Countries

Germany

Contacts

Public ContactAbdullah Salim

Augenklinik Petrisberg Trier

abdullah.salim@augenklinik-petrisberg.de06519984990

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026